1 / 5

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. Voors AA et al. Eur J Heart Fail. 2014 Feb 7. [ Epub ahead of print].

kevyn-matthews
Télécharger la présentation

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Systolic Heart failure treatment withthe Ifinhibitor ivabradine Trial The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT Voors AA et al. EurJ Heart Fail. 2014 Feb 7. [Epub ahead of print] www.shift-study.com

  2. 50 Placebo,renaldysfunction 40 Ivabradine,renal dysfunction 30 Patients (%) 20 10 0 0 6 12 18 24 30 Time (months) Effect of ivabradine on composite of CV death or HF hospitalization ] P=0.023 Placebo,norenaldysfunction ] P <0.001 Ivabradine,norenaldysfunction Voors AA et al. EurJ Heart Fail. 2014 Feb 7. [Epub ahead of print]

  3. Effect of ivabradine on other outcomes Voors AA et al. EurJ Heart Fail. 2014 Feb 7. [Epub ahead of print]

  4. Creatinine values over time with ivabradine and placebo 140 130 Placebo 120 Creatinine, μmol/L Ivabradine 110 100 90 80 70 Months 60 0 5 10 15 20 25 30 Voors AA et al. EurJ Heart Fail. 2014 Feb 7. [Epub ahead of print]

  5. Conclusions • In a large trial in patients with chronic systolic HF, renal function generally remained stable • However, if renal function worsened, it was strongly associated with an increased risk for events • Baseline heart rate was directly & independently associated with risk of worsening renal function • Treatment with ivabradine had a neutral effect on renal function during 2 years of follow-up • The beneficial prognostic effects and safety of ivabradine were similar in patients with and without renal dysfunction Voors AA et al. EurJ Heart Fail. 2014 Feb 7. [Epub ahead of print]

More Related